BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...

WEC Energy Group (NYSE:WEC – Free Report) had its price target increased by BMO Capital Markets from $95.00 to $100.00 in a research note released on Wednesday morning,Benzinga reports. BMO Capital ...

Operational resilience has become crucial for financial institutions navigating today's digital landscape riddled with cyber ...

Highlights,BMO Capital Markets reduces Ingredion's target price from $147.00 to $133.00, reflecting recent ...

BMO today announced it has joined the IBM Quantum Network, extending its technology leadership in North America to further drive real financial progress for its customers, clients, and the communities ...

A special Valentine's Day report from the BMO Real Financial Progress Index reveals 56% of Canadians say the rising cost of living is affecting dating, with many going on fewer dates and/or planning ...

Ahead of Valentine's Day, the BMO Real Financial Progress Index finds singles and couples alike are willing to spend a pretty penny to find love or keep that romantic spark alive. The average American ...

Co. Inc. (NYSE:MRK), reducing the pharmaceutical giant's price target from $105.00 to $96.00, while keeping a Market Perform rating on the stock. Analysts at BMO Capital cited a decrease in confidence ...

CEO Bourla sees "a lot of opportunities that probably outweigh the risks" with the Trump administration, like working together on cancer treatments ...